EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression, Distribution and Function of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in Endometrial Cancer

Thangesweran Ayakannu, Anthony H Taylor iD, Justin C Konje iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Thangesweran Ayakannu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocannabinoid Research Group, Reproductive Sciences Section, Department of Cancer Studies and Molecular Medicine, University of Leicester, Leiceste…. Hauptthemen laut MEDLINE: TRPV Cation Channels, Endometrial Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospitals of Leicester NHS Trust, postgraduate (MRCOG) courses run by Professor Konje at the University of Leicester.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transient receptor potential vanilloid 1 receptor (TRPV1) is a calcium-sensitive membrane receptor activated by capsaicin and the endocannabinoid, anandamide (AEA). Once activated in vitro, endometrial cancer (EC) cell growth appears to be inhibited through increased apoptosis, but the mechanism remains unclear. Our aim was to investigate the expression and distribution of TRPV1 in normal and cancerous endometria and to determine the precise in vitro mechanism of decreased EC cellular growth. TRPV1 expression in patients with endometrial carcinoma (15 Type 1 EC, six Type 2 EC) and six normal patients (atrophic endometria) was assessed using quantitative RT-PCR and immunohistochemistry (IHC). Additionally, immunohistochemical staining for the proliferation marker Ki-67, the pro-apoptotic marker BAX and the anti-apoptotic marker Bcl-2 were explored. TRPV1 transcript (p = 0.0054) and immunoreactive protein (p < 0.0001) levels were significantly reduced in all EC tissues when compared to control (atrophic) endometria. The almost 50% reduction in TRPV1 transcript levels was mirrored by an almost complete loss of immunoreactive TRPV1 protein. The increased proliferation (Ki-67) of EC tissues correlated with the expression of mutated BAX and inversely correlated to Bcl-2, but only in Type 2 EC samples. In vitro, AEA caused a decrease in Ishikawa cell numbers, whilst capsaicin did not, suggesting the anti-proliferative effect of AEA in EC cells is not via the TRPV1 receptor. In conclusion, the loss of TRPV1 expression in vivo plays a role in the aetiopathogenesis of EC. Activation of cells by AEA also probably promotes EC cell loss through a pro-apoptotic mechanism not involving TRPV1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPV Cation ChannelsEndometrial NeoplasmsHumansFemaleCell ProliferationMiddle Agedbcl-2-Associated X ProteinAgedGene Expression Regulation, NeoplasticApoptosisCell Line, TumorEndometriumProto-Oncogene Proteins c-bcl-2AdultCapsaicinKi-67 AntigenArachidonic Acids

Stichwörter der Autor:innen

anandamideapoptosiscell growthendocannabinoidendometrial cancervanilloid receptor

Substanzen

TRPV Cation ChannelsTRPV1 protein, humanbcl-2-Associated X ProteinProto-Oncogene Proteins c-bcl-2CapsaicinKi-67 AntigenArachidonic Acids

Autor:innen und Institutionen

  • Endocannabinoid Research Group, Reproductive Sciences Section, Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE1 7RH, UK.
  • Obstetrics & Gynaecology Centre of Excellence, Sunway Medical Centre, Petaling Jaya 47500, Malaysia.
  • Division of Obstetrics & Gynaecology, Department of Clinical Medicine and Surgery, Sunway University, Petaling Jaya 47500, Malaysia.
  • Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK.
  • Department of Health Sciences, University of Leicester, Leicester LE1 7RH, UK.

ORCID-Profile: Anthony H Taylor, Justin C Konje

Förderung

  • University Hospitals of Leicester NHS Trust
  • postgraduate (MRCOG) courses run by Professor Konje at the University of Leicester

Zitieren

APA

Ayakannu, T., Taylor, A. H., & Konje, J. C. (2025). Expression, Distribution and Function of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in Endometrial Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073104

Vancouver

Ayakannu T, Taylor AH, Konje JC. Expression, Distribution and Function of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in Endometrial Cancer. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073104

BibTeX
@article{Ayakannu2025,
  author = {Ayakannu, Thangesweran and Taylor, Anthony H and Konje, Justin C},
  title = {Expression, Distribution and Function of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in Endometrial Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073104}
}
Kostenlos starten →